Noncoding RNAs in hepatitis: Unraveling the apoptotic pathways

Area of Science:

• Hepatology
• Molecular Biology
• Genetics

Background:

• Hepatitis, often caused by viral infections like HBV and HCV, is a global health concern characterized by liver inflammation.
• Noncoding RNAs (ncRNAs), including microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs), are increasingly recognized for their regulatory roles in biological processes.
• Apoptosis, or programmed cell death, is vital for liver homeostasis but is dysregulated in hepatitis progression.

Purpose of the Study:

• To review the role of noncoding RNAs in mediating apoptosis during hepatitis.
• To explore the complex interplay between ncRNAs and apoptotic pathways in liver disease.
• To identify potential therapeutic targets and diagnostic biomarkers related to ncRNA-mediated apoptosis in hepatitis.

Main Methods:

• Literature review of recent research on noncoding RNAs and apoptosis in hepatitis.
• Analysis of studies investigating the expression patterns of ncRNAs in hepatitis-infected liver tissues.
• Examination of the molecular mechanisms linking ncRNAs to apoptotic effectors like caspases and Bcl-2 family proteins.

Main Results:

• Noncoding RNAs exhibit distinct expression patterns in different stages of hepatitis, indicating their dysregulation.
• ncRNAs significantly influence apoptosis by interacting with key regulators of cell survival and death pathways.
• The interplay between ncRNAs and apoptotic factors like caspases and Bcl-2 family members is critical in hepatitis pathogenesis.

Conclusions:

• Noncoding RNAs are integral to the apoptotic processes affected in hepatitis.
• Dysregulated ncRNAs in hepatitis present promising avenues for novel diagnostic and therapeutic interventions.
• Further research into ncRNA-mediated apoptosis could lead to improved management strategies for hepatitis.